Form 4: Zoetis Executive Vice President Nicholas Ashton Reports Stock Transactions

Executive Vice President Nicholas Ashton reports the acquisition and disposal of Zoetis Inc. common stock and restricted stock units.

Summary

• On February 6, 2025, Nicholas Ashton, Executive Vice President of Zoetis Inc., reported transactions involving the company's common stock and restricted stock units (RSUs).
• Ashton acquired 375 shares of common stock upon the vesting and settlement of RSUs.
• Ashton disposed of 196 shares to cover tax obligations at a price of $174.12 per share.
• Following these transactions, Ashton directly owns 825 shares of common stock.
• Ashton also holds 752 RSUs that vest in one-third increments on the anniversaries of February 6, 2024.
• Additionally, Ashton holds 786.4051 RSUs that vest in one-third increments on the anniversaries of February 8, 2023.
• Ashton also holds 170.6517 RSUs that vest on February 8, 2022.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the document primarily reports routine stock transactions. There are no explicit positive or negative implications for the company's performance.

Positives

• The vesting of RSUs indicates a continued alignment of the executive's interests with the company's performance.

Negatives

• The disposal of shares to cover tax obligations, while common, slightly reduces the executive's direct stake in the company.

Risks

• Future stock transactions by the executive could potentially influence the market price of Zoetis Inc. shares.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting schedule of the RSUs suggests continued equity-based compensation for the executive.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies and are routinely disclosed to ensure transparency. This filing provides insight into the compensation structure and equity ownership of a key executive at Zoetis, a major player in the animal health industry.

Comparison to Industry Standards

• Executive compensation practices, including the use of RSUs, are standard across publicly traded companies, particularly in the pharmaceutical and animal health sectors.
• Companies like Elanco and Merck Animal Health also utilize equity-based compensation to align executive interests with shareholder value.
• The vesting schedules and terms of the RSUs are generally consistent with industry norms for executive compensation packages.

Stakeholder Impact

• Shareholders are informed about the executive's stock ownership and transactions, promoting transparency.
• The transactions have a minor impact on the overall shareholding structure of the company.

Key Dates

Keywords

Zoetis, ZTS, Executive Vice President, Nicholas Ashton, Stock Transactions, Restricted Stock Units, RSU, Form 4, Beneficial Ownership